Clinical-trial operator Icon PLCICLR-0.60%decrease; red down pointing triangle said it would acquire rival PRA Health Sciences Inc. for $12 billion, creating a powerhouse provider of services to ...

"ICON Public Limited Company (NASDAQ:ICLR): The stock pulled back on news that biotechnology funding has dropped, albeit from ...

Special Counsel Says ICON CEO Steve Cutler says trial activity has been “impacted by cautious spending from biopharma customers in both the biotech and large pharma businesses.” The company ...

BALLERUP, Denmark & DUBLIN--(BUSINESS WIRE)--LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to ...

Clinical research organisation (CRO) Icon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the first CRO to completely integrate ...